Innate Pharma SA
IPHA· Nasdaq
Innate Pharma SA
- Last sale
- Oct 2, 2026 · -1.55%
- Market cap
- $149.01M
- 93.72M shares
- Filings
- 335
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | €9,005,000 | reported | |
| FY 2024 | 2024-12-31 | €20,121,000 | reported | |
| FY 2023 | 2023-12-31 | €61,641,000 | reported | |
| FY 2022 | 2022-12-31 | €57,674,000 | reported | |
| FY 2021 | 2021-12-31 | €24,703,000 | reported | |
| FY 2020 | 2020-12-31 | €69,773,000 revised | reported | |
| FY 2019 | 2019-12-31 | €85,449,000 revised | reported | |
| FY 2018 | 2018-12-31 | €93,952,000 | reported | |
| FY 2017 | 2017-12-31 | €44,033,000 | reported |
Innate Pharma SA · CIK 1598599 · Engraved from SEC EDGAR
